Stavros Stavrakis to Heart Failure
This is a "connection" page, showing publications Stavros Stavrakis has written about Heart Failure.
Connection Strength
7.325
-
Association between atrial fibrillation and heart failure patient reported outcomes across the ejection fraction spectrum. Am Heart J. 2024 07; 273:61-71.
Score: 0.755
-
Effect of Low-Level Tragus Stimulation on Cardiac Metabolism in Heart Failure with Preserved Ejection Fraction: A Transcriptomics-Based Analysis. Int J Mol Sci. 2024 Apr 13; 25(8).
Score: 0.753
-
Transcutaneous Vagus Nerve Stimulation Ameliorates the Phenotype of Heart Failure With Preserved Ejection Fraction Through Its Anti-Inflammatory Effects. Circ Heart Fail. 2022 08; 15(8):e009288.
Score: 0.666
-
Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial. J Am Heart Assoc. 2022 02; 11(3):e023582.
Score: 0.645
-
Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2021 05 01; 146:36-47.
Score: 0.603
-
Sex differences in the incidence and mode of death in rats with heart failure with preserved ejection fraction. Exp Physiol. 2021 03; 106(3):673-682.
Score: 0.602
-
Association of QRS narrowing with response to cardiac resynchronization therapy-a systematic review and meta-analysis of observational studies. Heart Fail Rev. 2020 09; 25(5):745-756.
Score: 0.586
-
Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans. J Cardiovasc Transl Res. 2019 06; 12(3):221-230.
Score: 0.521
-
Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction. Exp Physiol. 2019 01; 104(1):28-38.
Score: 0.519
-
Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis. Pacing Clin Electrophysiol. 2013 Nov; 36(11):1402-8.
Score: 0.358
-
Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function. Am J Med Sci. 2013 Mar; 345(3):211-7.
Score: 0.349
-
The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol. 2012 Feb; 23(2):163-8.
Score: 0.313
-
Machine learning versus conventional clinical methods in guiding management of heart failure patients-a systematic review. Heart Fail Rev. 2021 01; 26(1):23-34.
Score: 0.150
-
Effects of Low-Level Tragus Stimulation on Endothelial Function in Heart Failure With Reduced Ejection Fraction. J Card Fail. 2021 05; 27(5):568-576.
Score: 0.150
-
Impact of Implantable Cardioverter-Defibrillator Interventions on All-Cause Mortality in Heart Failure Patients: A Meta-Analysis. Cardiol Rev. 2019 May/Jun; 27(3):160-166.
Score: 0.134
-
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214.
Score: 0.090
-
Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace. 2012 Oct; 14(10):1490-7.
Score: 0.083
-
Autonomic Nervous System: A Therapeutic Target for Cardiac End-Organ Damage in Hypertension. Hypertension. 2024 Oct; 81(10):2027-2037.
Score: 0.048